Compare LONA & ALIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LONA | ALIS |
|---|---|---|
| Founded | 2011 | 2024 |
| Country | United States | United States |
| Employees | 26 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.7M | 84.3M |
| IPO Year | N/A | N/A |
| Metric | LONA | ALIS |
|---|---|---|
| Price | $8.98 | $10.04 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 37.1K | 3.3K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.21 | $9.87 |
| 52 Week High | $14.21 | $10.07 |
| Indicator | LONA | ALIS |
|---|---|---|
| Relative Strength Index (RSI) | 49.86 | 59.81 |
| Support Level | $4.55 | $9.97 |
| Resistance Level | $12.47 | $10.06 |
| Average True Range (ATR) | 1.19 | 0.01 |
| MACD | -0.31 | -0.00 |
| Stochastic Oscillator | 22.60 | 88.89 |
LeonaBio Inc is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).
Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.